SHL Telemedicine to acquire Jumedi GmbH a developer of Digital Health technologies Dienstag, 15. Dezember 2020 - 07:00

Press release

Tel Aviv / Zurich, December 15, 2020 – SHL Telemedicine Ltd. (SIX Swiss Exchange: SHLTN) ("SHL”), a leading provider and developer of advanced personal telemedicine solutions, announced today that its German subsidiary has concluded terms to acquire 100% of Jumedi GmbH. The closing of the transaction is expected at the beginning of next year.

Jumedi GmbH is a developer of a modular system for digital health applications (DiGA) and of “CareDoc” an innovative hybrid CRM system with integrated medical app, mainly being used by Healthcare Insurance companies in Germany. Jumedi GmbH was founded in 2017, employs about 20 people, mainly Software and IT Solutions developers, and about $ 3.5 million were invested in its operations since inception.

“The German Digital Healthcare Act is a first of its kind landmark legislation, supporting the shift to providing healthcare services by way of telemedicine and digital services” said Erez Nachtomy, CEO of SHL Telemedicine. “We welcome Jumedi to our SHL German operation. The technology developed by Jumedi, under the leadership of Mr. Linus Drop, will strengthen SHL’s position as a leader in the rapidly growing telemedicine market in Germany”.

For further information please contact:

Martin Meier-Pfister, IRF, Phone: +41 43 244 81 40, shl@irf-reputation.ch

About SHL Telemedicine

SHL Telemedicine is engaged in developing and marketing personal telemedicine systems and the provision of medical call center services, with a focus on cardiovascular and related diseases, to end users and to the healthcare community. SHL Telemedicine offers its services and personal telemedicine devices to subscribers utilizing telephonic and Internet communication technology. SHL is listed on the SIX Swiss Exchange (SHLTN, ISIN: IL0010855885, Security No.: 1128957). For more information, please visit our web site at www.shl-telemedicine.com.

Some of the information contained in this press release contains forward-looking statements. Readers are cautioned that any such forward-looking statements are not guarantees of future performance and involve risks and uncertainties, and that actual results may differ materially from those in the forward-looking statements as a result of various factors. SHL Telemedicine undertakes no obligation to publicly update or revise any forward-looking statements.